Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
This study has been completed.
Sponsor:
Kamada, Ltd.
Information provided by:
Kamada, Ltd.
ClinicalTrials.gov Identifier:
NCT00499837
First received: July 11, 2007
Last updated: December 30, 2009
Last verified: December 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2008 |
| Estimated Primary Completion Date: | No date given |